000 01794 a2200529 4500
005 20250517193201.0
264 0 _c20180827
008 201808s 0 0 eng d
022 _a1499-3872
024 7 _a10.1016/S1499-3872(17)60077-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMumtaz, Khalid
245 0 0 _aTrends and outcomes of transarterial chemoembolization in hepatocellular carcinoma: a national survey.
_h[electronic resource]
260 _bHepatobiliary & pancreatic diseases international : HBPD INT
_cDec 2017
300 _a624-630 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCarcinoma, Hepatocellular
_xeconomics
650 0 4 _aChemoembolization, Therapeutic
_xadverse effects
650 0 4 _aChi-Square Distribution
650 0 4 _aDatabases, Factual
650 0 4 _aFemale
650 0 4 _aHealth Care Surveys
650 0 4 _aHospital Charges
_xtrends
650 0 4 _aHospital Mortality
_xtrends
650 0 4 _aHumans
650 0 4 _aLength of Stay
_xtrends
650 0 4 _aLiver Neoplasms
_xeconomics
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aOdds Ratio
650 0 4 _aPalliative Care
_xeconomics
650 0 4 _aRisk Factors
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aPatel, Nishi
700 1 _aModi, Rohan M
700 1 _aPatel, Vihang
700 1 _aHinton, Alice
700 1 _aHanje, James
700 1 _aBlack, Sylvester M
700 1 _aKrishna, Somashaker
773 0 _tHepatobiliary & pancreatic diseases international : HBPD INT
_gvol. 16
_gno. 6
_gp. 624-630
856 4 0 _uhttps://doi.org/10.1016/S1499-3872(17)60077-8
_zAvailable from publisher's website
999 _c27938864
_d27938864